PT  - JOURNAL ARTICLE
AU  - Frank R Wendt
AU  - Carolina Muniz Carvalho
AU  - Joel Gelernter
AU  - Renato Polimanti
TI  - The effect of the genetic liability to autism spectrum disorder on emotion recognition in young unaffected probands from a population-based cohort
AID  - 10.1101/19001230
DP  - 2019 Jan 01
TA  - medRxiv
PG  - 19001230
4099  - http://medrxiv.org/content/early/2019/07/08/19001230.short
4100  - http://medrxiv.org/content/early/2019/07/08/19001230.full
AB  - We investigated how ASD genetic risk relates to neurodevelopmental features (491 traits tested) via polygenic risk scoring (PRS) in 4,309 young non-ASD probands from the Philadelphia Neurodevelopmental Cohort. ASD PRS most strongly associated with the ability to correctly identify angry facial emotions in youths aged 11-17 years (R2=1.06%, p=1.38×10−7) and replicated similarly in older probands (>18 years) (R2=0.55%, p=0.036). The association in 11- to-17-year-old probands was independent of other psychiatric disorders, brain imaging phenotypes, and educational attainment. ASD PRS also associated with proband-reported emotionality and connectedness with others. The proband-reported irritability trait was highly correlated with angry facial emotion recognition (r2=0.159, p=2.74×10−5) but was independently associated with ASD PRS (R2=1.20%, p=1.18×10−4). Several informant-reported (i.e., typically mother-reported) traits were predicted by the proband’s ASD PRS, including duration of fear (R2=0.156%, p=0.001). These data indicate how genetic liability to ASD may influence neurodevelopment in the general population, especially the development of emotional intelligence.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the Simons Foundation Autism Research Initiative (SFARI Explorer Award: 534858) and the American Foundation for Suicide Prevention (YIG-1-109-16). CMC was supported by a Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2018/05995-4) international fellowship. Support for the collection of the data for Philadelphia Neurodevelopment Cohort (PNC) was provided by grant RC2MH089983 awarded to Raquel Gur and RC2MH089924 awarded to Hakon Hakonarson. Subjects were recruited and genotyped through the Center for Applied Genomics (CAG) at The Children’s Hospital in Philadelphia (CHOP). Phenotypic data collection occurred at the CAG/CHOP and at the Brain Behavior Laboratory, University of Pennsylvania.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.NAAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.NAI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.NAAll data used in this study are either publicly available summary data or available for any research to submit an application through dbGAP.